Zobrazeno 1 - 10
of 384
pro vyhledávání: '"Hans-Theodor Eich"'
Autor:
Klaus Herfarth, Peter Borchmann, Sven Schnaidt, Karin Hohloch, Volker Budach, Marianne Engelhard, Andreas Viardot, Rita Engenhart-Cabillic, Ulrich Keller, Gabriele Reinartz, Hans-Theodor Eich, Mathias Witzens-Harig, Clemens F. Hess, Bernd Dörken, Jan Dürig, Thomas Wiegel, Wolfgang Hiddemann, Eva Hoster, Christiane Pott, Martin Dreyling
Publikováno v:
HemaSphere, Vol 2, Iss 6 (2018)
Abstract. The MabThera and Involved field Radiotherapy study investigated efficacy and safety of involved field (IF) radiotherapy in combination with the anti-CD20 antibody Rituximab for early-stage follicular lymphoma (FL) in a prospective, single-a
Externí odkaz:
https://doaj.org/article/3b975c9773894904a30ae659e98cefb3
Autor:
Isabel Falke, Khaled Elsayad, Mohammed Channaoui, Christian Kandler, Christos Moustakis, Hans Theodor Eich
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 31, Iss , Pp 100628- (2024)
Total skin electron beam therapy (TSEBT) in female patients with large or pendulous breasts is usually associated with shaded inframammary folds. In this analysis, 18 patients with cutaneous malignancy and pendulous breasts were irradiated with a rad
Externí odkaz:
https://doaj.org/article/e8572a3793ff46c6805dd720a48adaea
Autor:
Niklas Benedikt Pepper, Hans Theodor Eich, Michael Müther, Michael Oertel, Stephan Rehn, Dorothee Cäcilia Spille, Walter Stummer
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-8 (2024)
Abstract Background Despite improvements in surgical as well as adjuvant therapies over the last decades, the prognosis for patients with glioblastoma remains poor. Five-Aminolevulinic acid (5-ALA) induced porphyrins are already used for fluorescence
Externí odkaz:
https://doaj.org/article/f3cff0fb0d0641168e753c0de641fb38
Autor:
Katrin Borrmann, Fabian Martin Troschel, Kathrin Annemarie Brücksken, Nancy Adriana Espinoza-Sánchez, Maryam Rezaei, Kai Moritz Eder, Björn Kemper, Hans Theodor Eich, Burkhard Greve
Publikováno v:
Antioxidants, Vol 13, Iss 8, p 961 (2024)
Reducing side effects in non-cancerous tissue is a key aim of modern radiotherapy. Here, we assessed whether the use of the antioxidants hydroxytyrosol (HT) and thioredoxin-mimetic peptide CB3 (TMP) attenuated radiation-induced normal tissue toxicity
Externí odkaz:
https://doaj.org/article/a45b30b9c02d412fa8911c7168eb3edc
Autor:
Alice Heger, MS, Khaled Elsayad, PhD, Christian Kandler, MD, Jan Siats, MD, Michael Oertel, MD, Christopher Kittel, MD, Hans Theodor Eich, PhD
Publikováno v:
JAAD International, Vol 17, Iss , Pp 53-54 (2024)
Externí odkaz:
https://doaj.org/article/662c8069d6014d9d8eadd7415e48edc3
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-5 (2022)
Highlights Malignant melanoma patients reveal a characteristic and distinct immunological pattern. Elevated levels of soluble PD-L1 induced by previous immunotherapy were found. There were decreased levels of soluble PD-L2 in comparison to healthy co
Externí odkaz:
https://doaj.org/article/fda0aa5584b2472ea490ef1873f3a065
Autor:
Michael Oertel, Dominik Hering, Christian Baues, Christopher Kittel, Michael Fuchs, Jan Kriz, Kai Kröger, Dirk Vordermark, Klaus Herfarth, Rita Engenhart-Cabillic, Peter Lukas, Uwe Haverkamp, Peter Borchmann, Hans Theodor Eich
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionThe German Hodgkin Study Group (GHSG) HD17 trial established the omission of radiotherapy (RT) for patients with early-stage unfavorable Hodgkin lymphoma being PET-negative after 2 cycles of BEACOPP escalated plus 2 cycles of ABVD. This p
Externí odkaz:
https://doaj.org/article/bbcff74f33a749ce844db4900fab4337
Autor:
Fabian M. Troschel, Benjamin O. Troschel, Maren Kloss, Amelie S. Troschel, Niklas B. Pepper, Rainer G. Wiewrodt, Walter Stummer, Dorothee Wiewrodt, Hans Theodor Eich
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 40, Iss , Pp 100621- (2023)
Background and purpose: Glioblastoma (GBM) patients face a strongly unfavorable prognosis despite multimodal therapy regimens. However, individualized mortality prediction remains imprecise. Harnessing routine radiation planning cranial computed tomo
Externí odkaz:
https://doaj.org/article/3d55cb52ce2c411fb249157abab6236b
Autor:
Michael Oertel, MD, Dominik Hering, MSc, Nina Nacke, MSc, Christopher Kittel, MSc, Kai Kröger, MD, Jan Kriz, MD, Michael Fuchs, MD, Christian Baues, MD, Dirk Vordermark, MD, Rita Engenhart-Cabillic, MD, Klaus Herfarth, MD, Peter Lukas, MD, Heinz Schmidberger, MD, Simone Marnitz, MD, Peter Borchmann, MD, Andreas Engert, MD, Uwe Haverkamp, Hans Theodor Eich, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 3, Pp 101169- (2023)
Purpose: Radiation therapy (RT) is an integral part of treatment concepts for early-stage Hodgkin lymphoma. This analysis reports on RT quality in the recent HD16 and 17 trials of the German Hodgkin Study Group (GHSG). Methods and Materials: All RT p
Externí odkaz:
https://doaj.org/article/be482eea6f1c4df195be317ffeda2c0d
Autor:
Isabel Falke, Fabian M. Troschel, Heike Palenta, Maria T. Löblein, Kathrin Brüggemann, Katrin Borrmann, Hans Theodor Eich, Martin Götte, Burkhard Greve
Publikováno v:
Stem Cell Research & Therapy, Vol 13, Iss 1, Pp 1-16 (2022)
Abstract Background Endometrial carcinoma is the most common gynecological cancer in Europe. Musashi-1 is known to be a key regulator of endometrial cancer stem cells and a negative prognostic marker. In the present study, we aimed to understand grow
Externí odkaz:
https://doaj.org/article/2a9460a3e46b4df8b17448f2d9554235